lactose has been researched along with 1,2-dipalmitoylphosphatidylcholine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kinney, RC; Kohane, DS; Langer, R; Lipp, M; Lotan, N | 1 |
Anthony, DC; Kinney, RC; Kohane, DS; Langer, R; Lipp, M; Lotan, N; Louis, DN | 1 |
Arras, M; Codrons, V; Lison, D; Préat, V; Vanbever, R; Vanderbist, F; Verbeeck, RK | 1 |
Ahimou, F; Bosquillon, C; Culot, C; Préat, V; Rouxhet, PG; Simon, D; Vanbever, R | 1 |
Alpar, HO; Kaye, RS; Purewal, TS | 1 |
Akrivou, M; Bouropoulos, N; Eleftheriadis, GK; Fatouros, DG; Tsibouklis, J; Vizirianakis, IS | 1 |
6 other study(ies) available for lactose and 1,2-dipalmitoylphosphatidylcholine
Article | Year |
---|---|
Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anesthetics, Local; Animals; Bupivacaine; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Lactose; Male; Microspheres; Nerve Block; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serum Albumin | 2000 |
Biocompatibility of lipid-protein-sugar particles containing bupivacaine in the epineurium.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anesthetics, Local; Animals; Biocompatible Materials; Bupivacaine; Delayed-Action Preparations; Drug Delivery Systems; Inflammation; Lactic Acid; Lactose; Male; Microspheres; Nerve Block; Peripheral Nerves; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Serum Albumin; Time Factors | 2002 |
Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Animals; Drug Delivery Systems; Humans; Lactose; Male; Mass Spectrometry; Parathyroid Hormone; Particle Size; Peptide Fragments; Powders; Protein Binding; Rats; Rats, Wistar; Serum Albumin; Trehalose | 2003 |
Aerosolization properties, surface composition and physical state of spray-dried protein powders.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Albumins; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Stability; Excipients; Humans; Lactose; Particle Size; Porosity; Powders; Protein Denaturation; Spectrometry, X-Ray Emission; Surface Properties; Water; Wettability | 2004 |
Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antibodies; Chemistry, Pharmaceutical; Delayed-Action Preparations; Desiccation; Drug Carriers; Drug Delivery Systems; Excipients; Humans; Hydrogen-Ion Concentration; Lactic Acid; Lactose; Lung; Nanoparticles; Nanotechnology; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Powders; Solubility; Technology, Pharmaceutical; Time Factors; Water | 2009 |
Polymer-Lipid Microparticles for Pulmonary Delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Budesonide; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Female; Humans; Lactose; Leucine; Male; Mucus; Particle Size; Polyvinyl Alcohol; Pulmonary Surfactants | 2018 |